Now that Biomarin Pharmaceutical Inc’s volume has hit 1.97 million, investors get a glimpse of its size.
On Monday, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) was 5.02% up from the session before settling in for the closing price of $56.82. A 52-week range